TGFB1 and neoplasm: Especially in KPC3 tumors, this delay in tumor growth after early, but not late intervention with TGF-β-blocking antibodies was accompanied by a decreased intratumoral collagen deposition (Fig. 1E and F; Supplementary Fig. S2B).